Concepedia

C-L Law

CL

Statistics

Publications

5

Citations

279

H-Index

5

Active since

2001

Affiliations

Seagen (United States)(Current)

C-L Law is an author at Seagen (United States) specializing in oncology, medicine, and monoclonal antibodies in oncology.

Publications per year

2001–2011

5

Publications

5

Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody–drug conjugate SGN-75

Maureen C. Ryan, Heather Kostner, Karen A. Gordon et al. · British Journal of Cancer · 2010 · 86 citations · Full text

, , +17

Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40

Ezogelin Oflazoglu, Ivan J. Stone, Lindsay L. Brown et al. · British Journal of Cancer · 2008 · 81 citations · Full text

, , +16

Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's disease cells to conventional chemotherapeutics

Charles G. Cerveny, C-L Law, R S McCormick et al. · Leukemia · 2005 · 62 citations

, , +4

Characterization of calcitonin-containing liposome formulations for intranasal delivery

C-L Law · Journal of Microencapsulation · 2001 · 33 citations

, , +17

Proapoptotic signaling activity of the anti-CD40 monoclonal antibody dacetuzumab circumvents multiple oncogenic transformation events and chemosensitizes NHL cells

Timothy S. Lewis, R S McCormick, Ivan J. Stone et al. · Leukemia · 2011 · 17 citations

, , +12

1–5 of 5